179 related articles for article (PubMed ID: 12732183)
1. The Runx genes as dominant oncogenes.
Cameron ER; Blyth K; Hanlon L; Kilbey A; Mackay N; Stewart M; Terry A; Vaillant F; Wotton S; Neil JC
Blood Cells Mol Dis; 2003; 30(2):194-200. PubMed ID: 12732183
[TBL] [Abstract][Full Text] [Related]
2. The Runx genes: lineage-specific oncogenes and tumor suppressors.
Cameron ER; Neil JC
Oncogene; 2004 May; 23(24):4308-14. PubMed ID: 15156187
[TBL] [Abstract][Full Text] [Related]
3. Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging.
Blyth K; Terry A; Mackay N; Vaillant F; Bell M; Cameron ER; Neil JC; Stewart M
Oncogene; 2001 Jan; 20(3):295-302. PubMed ID: 11313958
[TBL] [Abstract][Full Text] [Related]
4. Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma.
Wotton S; Stewart M; Blyth K; Vaillant F; Kilbey A; Neil JC; Cameron ER
Cancer Res; 2002 Dec; 62(24):7181-5. PubMed ID: 12499254
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic potential of the RUNX gene family: 'overview'.
Ito Y
Oncogene; 2004 May; 23(24):4198-208. PubMed ID: 15156173
[TBL] [Abstract][Full Text] [Related]
6. The common retroviral insertion locus Dsi1 maps 30 kilobases upstream of the P1 promoter of the murine Runx3/Cbfa3/Aml2 gene.
Stewart M; MacKay N; Cameron ER; Neil JC
J Virol; 2002 May; 76(9):4364-9. PubMed ID: 11932403
[TBL] [Abstract][Full Text] [Related]
7. Enforced expression of Runx2 perturbs T cell development at a stage coincident with beta-selection.
Vaillant F; Blyth K; Andrew L; Neil JC; Cameron ER
J Immunol; 2002 Sep; 169(6):2866-74. PubMed ID: 12218099
[TBL] [Abstract][Full Text] [Related]
8. Upstream and downstream targets of RUNX proteins.
Otto F; Lübbert M; Stock M
J Cell Biochem; 2003 May; 89(1):9-18. PubMed ID: 12682904
[TBL] [Abstract][Full Text] [Related]
9. Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo.
Blyth K; Vaillant F; Hanlon L; Mackay N; Bell M; Jenkins A; Neil JC; Cameron ER
Cancer Res; 2006 Feb; 66(4):2195-201. PubMed ID: 16489021
[TBL] [Abstract][Full Text] [Related]
10. Expression of Runx1, -2 and -3 during tooth, palate and craniofacial bone development.
Yamashiro T; Aberg T; Levanon D; Groner Y; Thesleff I
Gene Expr Patterns; 2002 Nov; 2(1-2):109-12. PubMed ID: 12617847
[TBL] [Abstract][Full Text] [Related]
11. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc.
Vaillant F; Blyth K; Terry A; Bell M; Cameron ER; Neil J; Stewart M
Oncogene; 1999 Nov; 18(50):7124-34. PubMed ID: 10597314
[TBL] [Abstract][Full Text] [Related]
12. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.
Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y
Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419
[TBL] [Abstract][Full Text] [Related]
13. Runx transcription factors and the developmental balance between cell proliferation and differentiation.
Coffman JA
Cell Biol Int; 2003; 27(4):315-24. PubMed ID: 12788047
[TBL] [Abstract][Full Text] [Related]
14. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
Baxter EW; Blyth K; Cameron ER; Neil JC
J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
[TBL] [Abstract][Full Text] [Related]
15. Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.
Terry A; Kilbey A; Vaillant F; Stewart M; Jenkins A; Cameron E; Neil JC
Gene; 2004 Jul; 336(1):115-25. PubMed ID: 15225881
[TBL] [Abstract][Full Text] [Related]
16. RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53.
Wotton SF; Blyth K; Kilbey A; Jenkins A; Terry A; Bernardin-Fried F; Friedman AD; Baxter EW; Neil JC; Cameron ER
Oncogene; 2004 Jul; 23(32):5476-86. PubMed ID: 15133495
[TBL] [Abstract][Full Text] [Related]
17. Expression of lymphomagenic oncogenes in T-cell lymphomas of HPV 16 transgenic mice.
Yang JT; Liu CZ; Domer P; Iannaccone P
Cancer Detect Prev; 1998; 22(5):405-15. PubMed ID: 9727621
[TBL] [Abstract][Full Text] [Related]
18. The RUNX Genes as Conditional Oncogenes: Insights from Retroviral Targeting and Mouse Models.
Neil JC; Gilroy K; Borland G; Hay J; Terry A; Kilbey A
Adv Exp Med Biol; 2017; 962():247-264. PubMed ID: 28299662
[TBL] [Abstract][Full Text] [Related]
19. Role of RUNX family members in transcriptional repression and gene silencing.
Durst KL; Hiebert SW
Oncogene; 2004 May; 23(24):4220-4. PubMed ID: 15156176
[TBL] [Abstract][Full Text] [Related]
20. Possible roles of Runx1 and Sox9 in incipient intramembranous ossification.
Yamashiro T; Wang XP; Li Z; Oya S; Aberg T; Fukunaga T; Kamioka H; Speck NA; Takano-Yamamoto T; Thesleff I
J Bone Miner Res; 2004 Oct; 19(10):1671-7. PubMed ID: 15355562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
